论文部分内容阅读
糖尿病(DM)的病原异种性及患者未遵照医瞩控制饮食,可使门诊医师对治疗方案的正确选择产生困难,因而须住院治疗。故人们希望有一种能把患者分为胰岛素依赖型(IDDM)和非胰岛素依赖型(NIDDM)的实用的临床试验。本文旨在评定C肽对胰高血糖素刺激反应在选择DM的正确治疗方案上的实用价值。作者选定门诊患者268例。这些患者除DM外无其他已知的疾病,而且血清肌酐水平均正常
The pathogenic heterogeneity of diabetes mellitus (DM) and the failure of patients to follow a doctor-centered diet can make an attending physician difficult to make the right choice of treatment and therefore require hospitalization. Therefore, one would like to have a practical clinical trial that divides patients into insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) patients. This article aims to assess the practical value of C-peptide in the correct treatment of glucagon-stimulated responses in the selection of DM. The authors selected 268 outpatients. These patients had no known disease other than DM, and serum creatinine levels were normal